{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:50:00Z","timestamp":1783122600178,"version":"3.54.6"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.8531","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T22:58:48Z","timestamp":1360882728000},"page":"483-488","source":"Crossref","is-referenced-by-count":23,"title":["Central Nervous System Lymphoma Initially Diagnosed as Tumefactive Multiple Sclerosis after Brain Biopsy"],"prefix":"10.2169","volume":"52","author":[{"given":"Yasuko","family":"Ohe","sequence":"first","affiliation":[{"name":"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Uchino","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Vaquero J, Martinez R, Ross E, et al. Primary cerebral lymphoma: the \"ghost tumor\" Case report. J Neurosurg 60: 174-176, 1984."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alderson L, Fetell MR, Sisti M, et al. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 60: 102-105, 1996.","DOI":"10.1136\/jnnp.60.1.102"},{"key":"3","unstructured":"3. Suzuki M, Uchiyama T, Takahashi H, et al. A case of primary sentral nervous system lymphoma preceded by cerebral and cerebellar lesion diminishing spontanepously: Consideration of two brain biopsy at the onset and after two years. Clin Neurol 49: 586-589, 2009."},{"key":"4","unstructured":"4. Kuroda Y, Kawasaki T, Haraoka S, et al. Autopsy report of primary CNS B-cell lymphoms indistinguishable from multiple sclerosis: diagnosis with the immunoglobulin gene rearrangements analysis. J Neurological Sciences 111: 173-179, 1992."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ng S, Butzkueven H, Kalnins R, et al. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neuro 14: 1126-1129, 2007.","DOI":"10.1016\/j.jocn.2006.05.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the USA. Cancer 62: 2461-2465, 1988.","DOI":"10.1002\/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. O'Neill BP, Illig JJ. Primary central nervous system lymphoma. Mayo Clin Proc 64: 1005-1020, 1989.","DOI":"10.1016\/S0025-6196(12)61228-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201: 195-200, 2005.","DOI":"10.1084\/jem.20041674"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kuhlmann T, Schroter A, Dechent P, et al. Diagnosis of a multifocal B cell lymphoma wiyh preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 70: 259-262, 2001.","DOI":"10.1136\/jnnp.70.2.259"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Husseini L, Saleh A, Reifenberger G, et al. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma. Can J Neurol Sci 39: 6-10, 2012.","DOI":"10.1017\/S0317167100012610"},{"key":"11","unstructured":"11. Chayasirisobhon S, Kumar V, Ali I, et al. Primary lymphoma of the central nervous system: a diagnostic problem. J Natl Med Assoc 79: 198-200, 1987."},{"key":"12","unstructured":"12. Bender PG, Schapiro TR. Primary CNS lymphoma presenting as multiple sclerosis. Minnesota Medicine 72: 157-160, 1989."},{"key":"13","unstructured":"13. Rosenfeld SS, Hoffman JM, Coleman RE, et al. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxygluose positron emission tomography. J Nucl Med 33: 532-536, 1992."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kosaka N, Tsuchida T, Uematsu H, et al. <sup>18<\/sup>F-FDG of common enhancing malignant brain tumor. Neuroradiology 190: 365-369, 2008.","DOI":"10.2214\/AJR.07.2660"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pirotte B, Goldman S, Massager N, et al. Combined use of <sup>18<\/sup>F-fluorodeoxyglucose and <sup>11<\/sup>C-methionine in 45 positron emission tomography-guided stereotatic brain biopsies. J Neurosurg 101: 476-483, 2004.","DOI":"10.3171\/jns.2004.101.3.0476"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Herholz K, Holzer T, Bauer B, et al. <sup>11<\/sup>C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50: 1316-1322, 1998.","DOI":"10.1212\/WNL.50.5.1316"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chung JK, Kim YK, Kim S, et al. Usefulness of <sup>11<\/sup>C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on <sup>18<\/sup>F-FDG PET. Eur J Nucl Med 29: 176-182, 2002.","DOI":"10.1007\/s00259-001-0690-4"},{"key":"18","unstructured":"18. Kawai N, Okauchi M, Miyake K, et al. <sup>11<\/sup>C-methionime positron emission tomography in nontumorous brain lesions. No Shinkei Gaku 38: 985-995, 2010 (in Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33: 480-489, 1993.","DOI":"10.1002\/ana.410330511"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32: 758-766, 1992.","DOI":"10.1002\/ana.410320609"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/4\/52_52.8531\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:48:19Z","timestamp":1621446499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/4\/52_52.8531\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.8531","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}